Article Versions Notes

Su Y-L, Tsai K-L, Chiu T-J, Lin Y-M, Lee K-C, Lu C-C, Chen H-H, Wu C-C, Hsu H-C. Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment. Cancers. 2021; 13(20):5080. https://doi.org/10.3390/cancers13205080

Su, Yu-Li, Kai-Lung Tsai, Tai-Jan Chiu, Yueh-Ming Lin, Ko-Chao Lee, Chien-Chang Lu, Hong-Hwa Chen, Chia-Che Wu, and Hung-Chih Hsu. 2021. "Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment" Cancers 13, no. 20: 5080. https://doi.org/10.3390/cancers13205080

Su, Y. -L., Tsai, K. -L., Chiu, T. -J., Lin, Y. -M., Lee, K. -C., Lu, C. -C., Chen, H. -H., Wu, C. -C., & Hsu, H. -C. (2021). Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment. Cancers, 13(20), 5080. https://doi.org/10.3390/cancers13205080